Ignite Creation Date:
2024-05-06 @ 10:27 AM
Last Modification Date:
2024-10-26 @ 12:30 PM
Study NCT ID:
NCT03267940
Status:
TERMINATED
Last Update Posted:
2020-02-07
First Post:
2017-07-25
Brief Title:
Study of PEGPH20 With Cisplatin CIS and Gemcitabine GEM PEGPH20 With Atezolizumab ATEZO CIS and GEM and CIS and GEM Alone in Participants With Previously Untreated Unresectable Locally Advanced or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder Adenocarcinoma
Sponsor:
Halozyme Therapeutics
Organization:
Halozyme Therapeutics
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-10-02
Start Date Type:
ACTUAL
Primary Completion Date:
2019-11-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-11-11
Completion Date Type:
ACTUAL
First Submit Date:
2017-07-25
First Submit QC Date:
August 28 2017
Study First Post Date:
2017-08-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2020-02-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-01-24
Last Update Post Date:
2020-02-07
Last Update Post Date Type:
ACTUAL